Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Kitas

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year StudyChris J Kapelios, Antonios A Argyris, Athanase D Protogerou, et al.
Angiology|September 22, 2018
Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective StudyMina Psichogiou, Chris J Kapelios, Giorgos Konstantonis, et al.
Inflammation & Allergy Drug Targets|November 22, 2014
Clinical queries addressed in patients with systemic autoimmune diseases. Can cardiovascular magnetic resonance give the final solution?Sophie Mavrogeni, Georgia Karabela, Elias Gialafos, et al.
Rheumatology (Oxford, England)|November 30, 2014
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroidsFowzia Ibrahim, Ernest Choy, Patrick Gordon, et al.
Rheumatology International|January 2, 2025
Artificial intelligence-based cardiovascular/stroke risk stratification in women affected by autoimmune disorders: a narrative surveyEkta Tiwari, Dipti Shrimankar, Mahesh Maindarkar, et al.
Computers in Biology and Medicine|August 10, 2020
Two-stage artificial intelligence model for jointly measurement of atherosclerotic wall thickness and plaque burden in carotid ultrasound: A screening tool for cardiovascular/stroke risk assessmentMainak Biswas, Luca Saba, Shubhro Chakrabartty, et al.
The Israel Medical Association Journal : IMAJ|April 30, 2019
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through SynergyLazaros I Sakkas, Dimitrios P Bogdanos, Dimitrios Boumpas, et al.
RMD Open|July 23, 2024
Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritisGeorge Athanasios Karpouzas, Sarah R Ormseth, Piet Leonardus Cornelis Maria van Riel, et al.
RMD Open|April 5, 2025
Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic useGeorge Athanasios Karpouzas, Miguel A Gonzalez-Gay, Alfonso Corrales, et al.
Eclinicalmedicine|June 7, 2024
Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping reviewManasvi Singh, Ashish Kumar, Narendra N Khanna, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year StudyChris J Kapelios, Antonios A Argyris, Athanase D Protogerou, et al.
Angiology|September 22, 2018
Prevalence, Incidence, and Contributors of Subclinical Atheromatosis, Arteriosclerosis, and Arterial Hypertrophy in HIV-Infected Individuals: A Single-Center, 3-Year Prospective StudyMina Psichogiou, Chris J Kapelios, Giorgos Konstantonis, et al.
Inflammation & Allergy Drug Targets|November 22, 2014
Clinical queries addressed in patients with systemic autoimmune diseases. Can cardiovascular magnetic resonance give the final solution?Sophie Mavrogeni, Georgia Karabela, Elias Gialafos, et al.
Rheumatology (Oxford, England)|November 30, 2014
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroidsFowzia Ibrahim, Ernest Choy, Patrick Gordon, et al.
Rheumatology International|January 2, 2025
Artificial intelligence-based cardiovascular/stroke risk stratification in women affected by autoimmune disorders: a narrative surveyEkta Tiwari, Dipti Shrimankar, Mahesh Maindarkar, et al.
Computers in Biology and Medicine|August 10, 2020
Two-stage artificial intelligence model for jointly measurement of atherosclerotic wall thickness and plaque burden in carotid ultrasound: A screening tool for cardiovascular/stroke risk assessmentMainak Biswas, Luca Saba, Shubhro Chakrabartty, et al.
The Israel Medical Association Journal : IMAJ|April 30, 2019
The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through SynergyLazaros I Sakkas, Dimitrios P Bogdanos, Dimitrios Boumpas, et al.
RMD Open|July 23, 2024
Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritisGeorge Athanasios Karpouzas, Sarah R Ormseth, Piet Leonardus Cornelis Maria van Riel, et al.
RMD Open|April 5, 2025
Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic useGeorge Athanasios Karpouzas, Miguel A Gonzalez-Gay, Alfonso Corrales, et al.
Eclinicalmedicine|June 7, 2024
Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping reviewManasvi Singh, Ashish Kumar, Narendra N Khanna, et al.
Pageof 5